{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:41:12Z","timestamp":1762659672633},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"G&E Herbal Biotechnology Company"},{"name":"Ministry of Economic Affairs of Taiwan","award":["100-EC-17-A-20-I1-0116"],"award-info":[{"award-number":["100-EC-17-A-20-I1-0116"]}]}],"content-domain":{"domain":["clinicalkey.jp","jdsjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jdermsci.2018.02.015","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T12:22:05Z","timestamp":1519993325000},"page":"295-302","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy and safety of topical SR-T100 gel in treating actinic keratosis in Taiwan: A Phase III randomized double-blind vehicle-controlled parallel trial"],"prefix":"10.1016","volume":"90","author":[{"given":"Chao-Chun","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tak-Wah","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Hui","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Hsing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Jie","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Chi","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Kai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsi","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamm-Ming","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Che E.","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jdermsci.2018.02.015_bib0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000076016","article-title":"Actinic keratosis: the key event in the evolution from photoaged skin to squamous cell carcinoma. Therapy based on pathogenetic and clinical aspects","volume":"17","author":"Oppel","year":"2004","journal-title":"Skin Pharmacol. Physiol."},{"issue":"1 Pt 2","key":"10.1016\/j.jdermsci.2018.02.015_bib0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1067\/mjd.2000.103342","article-title":"Epidemiology of actinic keratoses and squamous cell carcinoma","volume":"2","author":"Salasche","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.jdermsci.2018.02.015_bib0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archderm.1988.01670010036018","article-title":"Health effects of sunlight exposure in the United States. results from the first national health and nutrition examination survey 1971\u20131974","volume":"124","author":"Engel","year":"1988","journal-title":"Arch. Dermatol."},{"issue":"8","key":"10.1016\/j.jdermsci.2018.02.015_bib0020","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/bjc.1996.535","article-title":"Non-melanoma skin cancer and solar keratoses II analytical results of the South Wales Skin Cancer Study","volume":"74","author":"Harvey","year":"1996","journal-title":"Br. J. Cancer"},{"issue":"Suppl 2","key":"10.1016\/j.jdermsci.2018.02.015_bib0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2133.2007.08267.x","article-title":"Pathology and pathobiology of actinic (solar) keratosis \u2212 an update","volume":"157","author":"Roewert-Huber","year":"2007","journal-title":"Br. J. Dermatol."},{"issue":"8589","key":"10.1016\/j.jdermsci.2018.02.015_bib0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(88)91658-3","article-title":"Malignant transformation of solar keratoses to squamous cell carcinoma","volume":"1","author":"Marks","year":"1988","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jdermsci.2018.02.015_bib0035","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.jid.5700110","article-title":"Reliable methods to evaluate the burden of actinic keratoses","volume":"126","author":"Atkins","year":"2006","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.jdermsci.2018.02.015_bib0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1067\/mjd.2003.186","article-title":"Skin cancer is among the most costly of all cancers to treat for the Medicare population","volume":"48","author":"Housman","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.jdermsci.2018.02.015_bib0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0190-9622(99)70526-8","article-title":"Destructive procedures are the standard of care for treatment of actinic keratoses","volume":"40","author":"Feldman","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"issue":"5","key":"10.1016\/j.jdermsci.2018.02.015_bib0050","first-page":"241","article-title":"What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: overview and investigational topical agents","volume":"89","author":"Berman","year":"2012","journal-title":"Cutis"},{"key":"10.1016\/j.jdermsci.2018.02.015_bib0055","first-page":"37","article-title":"Textual research of Long-K\u2019uei on pents\u2019aology and pharmaceutical botany","volume":"18","author":"Liu","year":"2007","journal-title":"J. Chin. Med."},{"issue":"3705","key":"10.1016\/j.jdermsci.2018.02.015_bib0060","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1126\/science.150.3705.1827","article-title":"Beta-solamarine: tumor inhibitor isolated from Solanum dulcamara","volume":"150","author":"Kupchan","year":"1965","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jdermsci.2018.02.015_bib0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1055\/s-2006-962612","article-title":"Antitumour effects of glycoalkaloids isolated from Solanum sodomaeum","volume":"53","author":"Cham","year":"1987","journal-title":"Planta Med."},{"issue":"2","key":"10.1016\/j.jdermsci.2018.02.015_bib0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0304-3835(87)90081-4","article-title":"Glycoalkaloids from Solanum sodomaeum are effective in the treatment of skin cancers in man","volume":"36","author":"Cham","year":"1987","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.jdermsci.2018.02.015_bib0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0304-3835(90)90122-E","article-title":"Solasodine glycosides. Selective cytotoxicity for cancer cells and inhibition of cytotoxicity by rhamnose in mice with sarcoma 180","volume":"55","author":"Cham","year":"1990","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.jdermsci.2018.02.015_bib0080","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1021\/jf030526d","article-title":"Glycoalkaloids and metabolites inhibit the growth of human colon (HT29) and liver (HepG2) cancer cells","volume":"52","author":"Lee","year":"2004","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.jdermsci.2018.02.015_bib0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/bbrc.1997.7903","article-title":"The rhamnose moiety of solamargine plays a crucial role in triggering cell death by apoptosis","volume":"242","author":"Chang","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.jdermsci.2018.02.015_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/bbrc.1996.1748","article-title":"Solamargine purified from Solanum incanum Chinese herb triggers gene expression of human TNFR I which may lead to cell apoptosis","volume":"229","author":"Hsu","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.jdermsci.2018.02.015_bib0095","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.bbrc.2004.07.183","article-title":"Action of solamargine on TNFs and cisplatin-resistant human lung cancer cells","volume":"322","author":"Liang","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.jdermsci.2018.02.015_bib0100","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/S0006-2952(00)00506-2","article-title":"Anticancer activity evaluation of the solanum glycoalkaloid solamargine. Triggering apoptosis in human hepatoma cells","volume":"60","author":"Kuo","year":"2000","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.jdermsci.2018.02.015_bib0105","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.fct.2007.05.009","article-title":"Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin","volume":"45","author":"Shiu","year":"2007","journal-title":"Food Chem. Toxicol."},{"issue":"1\u20132","key":"10.1016\/j.jdermsci.2018.02.015_bib0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.febslet.2004.09.064","article-title":"Action of solamargine on human lung cancer cells\u2013enhancement of the susceptibility of cancer cells to TNFs","volume":"577","author":"Liu","year":"2004","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.jdermsci.2018.02.015_bib0115","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1021\/np50068a041","article-title":"The cytotoxic principles of Solanum incanum","volume":"53","author":"Lin","year":"1990","journal-title":"J. Nat. Prod."},{"issue":"1","key":"10.1016\/j.jdermsci.2018.02.015_bib0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-1999-13958","article-title":"Antineoplastic agents. III: steroidal glycosides from solanum nigrum","volume":"65","author":"Hu","year":"1999","journal-title":"Planta Med."},{"issue":"2","key":"10.1016\/j.jdermsci.2018.02.015_bib0125","first-page":"83","article-title":"Solanum incanum extract (SR-T100) induces human cutaneous squamous cell carcinoma apoptosis through modulating tumor necrosis factor receptor signaling pathway","volume":"63","author":"Wu","year":"2011","journal-title":"J. Dermatol. Sci."},{"issue":"61","key":"10.1016\/j.jdermsci.2018.02.015_bib0130","doi-asserted-by":"crossref","first-page":"103509","DOI":"10.18632\/oncotarget.21508","article-title":"Solanum incanum extract (SR-T100) induces melanoma cell apoptosis and inhibits established lung metastasis","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jdermsci.2018.02.015_bib0135","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000366536","article-title":"Clinical features of actinic keratoses and early squamous cell carcinoma","volume":"46","author":"Wheller","year":"2015","journal-title":"Curr. Probl. Dermatol."},{"key":"10.1016\/j.jdermsci.2018.02.015_bib0140","doi-asserted-by":"crossref","first-page":"364","DOI":"10.5227\/skincancer.26.364","article-title":"Randomized, double-blind, parallel-group, vehicle-controlled, multicenter study of imiquimod 5% cream in patients with actinic keratosis","volume":"26","author":"Saida","year":"2011","journal-title":"Skin Cancer (Japan)"},{"issue":"1","key":"10.1016\/j.jdermsci.2018.02.015_bib0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1600-0781.2009.00401.x","article-title":"A pilot study to assess the efficacy of photodynamic therapy for Japanese patients with actinic keratosis in relation to lesion size and histological severity","volume":"25","author":"Nakano","year":"2009","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"issue":"9","key":"10.1016\/j.jdermsci.2018.02.015_bib0150","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1524-4725.2012.02480.x","article-title":"Treatment-refractory actinic keratoses successfully treated using simultaneous combination topical 5-fluorouracil cream and imiquimod cream: a case-control study","volume":"38","author":"Ondo","year":"2012","journal-title":"Dermatol. Surg."},{"issue":"5","key":"10.1016\/j.jdermsci.2018.02.015_bib0155","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1524-4725.1985.tb01413.x","article-title":"Metastatic squamous-cell carcinomas derived from solar keratosis","volume":"11","author":"Fukamizu","year":"1985","journal-title":"J. Dermatol. Surg. Oncol."},{"issue":"9","key":"10.1016\/j.jdermsci.2018.02.015_bib0160","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1365-4632.2012.05776.x","article-title":"Understanding efficacy end-points in studies of field-directed therapy for actinic keratosis","volume":"52","author":"Rigel","year":"2013","journal-title":"Int. J. Dermatol."},{"issue":"2","key":"10.1016\/j.jdermsci.2018.02.015_bib0165","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2340\/00015555-0213","article-title":"Assessing clinically meaningful end points for the management of actinic keratosis with diclofenac 3% gel","volume":"87","author":"Rivers","year":"2007","journal-title":"Acta Derm. Venereol."},{"issue":"6","key":"10.1016\/j.jdermsci.2018.02.015_bib0170","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jaad.2009.01.008","article-title":"Randomized double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis","volume":"60","author":"Anderson","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.jdermsci.2018.02.015_bib0175","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.141.4.467","article-title":"Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3 randomized, double-blind, parallel-group, vehicle-controlled trials","volume":"141","author":"Korman","year":"2005","journal-title":"Arch. Dermatol."},{"issue":"1","key":"10.1016\/j.jdermsci.2018.02.015_bib0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2133.2007.07942.x","article-title":"Vehicle-controlled randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3\u202fdays per week in one or two courses of treatment of actinic keratoses on the head","volume":"157","author":"Alomar","year":"2007","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.jdermsci.2018.02.015_bib0185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13555-014-0059-9","article-title":"A new objective, quantitative scale for measuring local skin responses following topical actinic keratosis therapy with ingenol mebutate","volume":"4","author":"Rosen","year":"2014","journal-title":"Dermatol. Ther. (Heidelb)"},{"issue":"1","key":"10.1016\/j.jdermsci.2018.02.015_bib0190","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s13555-016-0161-2","article-title":"Efficacy and safety of 5-Fluorouracil 0.5%\/Salicylic acid 10% in the field-Directed treatment of actinic keratosis: a phase III, randomized, double-Blind, vehicle-Controlled trial","volume":"7","author":"Stockfleth","year":"2017","journal-title":"Dermatol. Ther. (Heidelb)"},{"issue":"1","key":"10.1016\/j.jdermsci.2018.02.015_bib0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-4632.2007.03060.x","article-title":"Topical diclofenac in the treatment of actinic keratoses","volume":"46","author":"Merk","year":"2007","journal-title":"Int. J. Dermatol."},{"issue":"4","key":"10.1016\/j.jdermsci.2018.02.015_bib0200","first-page":"927","article-title":"The value of the histopathologic examination in the diagnosis and management of the actinic keratosis","volume":"53","author":"Vilcea","year":"2012","journal-title":"Rom. J. Morphol. Embryol."},{"issue":"3","key":"10.1016\/j.jdermsci.2018.02.015_bib0205","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/ajd.12004","article-title":"Face-masks for facial atopic eczema: consider a hydrocolloid dressing","volume":"54","author":"Rademaker","year":"2013","journal-title":"Australas. J. Dermatol."},{"issue":"8","key":"10.1016\/j.jdermsci.2018.02.015_bib0210","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2340\/00015555-2134","article-title":"The role of wet wrap therapy in skin disorders \u2013 a literature review","volume":"95","author":"Andersen","year":"2015","journal-title":"Acta Derm. Venereol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181118301099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181118301099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T17:53:49Z","timestamp":1535046829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181118301099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0923181118301099"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2018.02.015","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of topical SR-T100 gel in treating actinic keratosis in Taiwan: A Phase III randomized double-blind vehicle-controlled parallel trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2018.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}